“Umbilical Cord Tissue-derived Mesenchymal Stem Cells Should be Considered as Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence” (2021) Biomedical Research and Therapy, 8(9), pp. 4583–4595. doi:10.15419/bmrat.v8i9.694.